Provider review
Zealthy review
FDA warning letter, a Novo Nordisk suit, and an FTC data-privacy case
Compounded semaglutide runs from $151 a month on a three-month prepay. The paper trail matters more: an FDA warning letter over false-or-misleading compounded-semaglutide claims, a Novo Nordisk lawsuit, and a federal complaint naming Zealthy over buried cancellation terms and health-data sharing.
Received an FDA warning letter in September 2025 — see the FDA’s warning-letter database.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Zealthy carries more independently verifiable regulatory and legal exposure than any other provider reviewed on this site: a real FDA warning letter over false-or-misleading compounded-semaglutide claims, a real Novo Nordisk lawsuit alleging the same core deception, and a real federal complaint naming Zealthy and an affiliated entity directly over allegedly buried cancellation terms and health-data sharing — the same category of conduct the founder's prior company, Cerebral, settled with the FTC over for $7 million. None of this means every claim in every complaint will be proven, but it is a documented, ongoing pattern worth weighing heavily before enrolling.
Zealthy is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You've read the FDA warning letter and the federal complaints yourself and are comfortable proceeding anyway
- You want an asynchronous option that doesn't always require a video visit
- You're comparing pricing only and plan to verify every other claim independently before paying
Look elsewhere if
- You want a provider without an open FDA warning letter over how it markets its compounded medication
- You want a cancellation and data-privacy policy that hasn't been the subject of a federal complaint alleging it's deceptive
- You want a stable, single, easily-verified legal entity — this one has operated under at least three different names
What it actually costs
What they advertise
Compounded semaglutide: from $151/mo on a 3-month prepay on getzealthy.com.
What you actually pay, month to month
Bundled "Doctor + GLP-1" semaglutide plan runs $217 first month, then $297/mo ongoing; tirzepatide bundle runs $349 then $449/mo.
The commitment trap
The $151 headline requires a 3-month prepay — the bundled month-to-month plan runs nearly double at $297/mo ongoing.
Checked live on Zealthy's own site at https://getzealthy.com/weight-loss-faq in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Zealthy bundles in, and what it does not.
Clinician consult
Async questionnaire or monthly video/phone check-ins.
Bloodwork / labs
Not published.
Follow-ups and dose changes
Monthly check-ins.
Human support
Not published.
Injection supplies
Included in the price.
Shipping
No terms published.
Pharmacy, labs and oversight
The pharmacy
Not named in any source read.
Oversight
Monthly check-ins.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
"All 50 states," — a correction to a prior 34-state figure.
The honest cons
The part they would rather you skipped
Zealthy's founder's prior company, Cerebral, settled with the FTC for $7 million over deceptive cancellation policies and misused health data, per the FTC's own press release — and a federal complaint now names Zealthy and an affiliated entity directly over an almost identical pattern: fine-print cancellation limits and undisclosed health-data sharing, confirmed by reading the amended complaint itself.
- Open FDA warning letter (September 2025) over false-or-misleading compounded-semaglutide marketing claims
- Named defendant in a Novo Nordisk lawsuit alleging its products are marketed as equivalent to FDA-approved medicines
- Named, via an affiliated entity, in a federal complaint alleging buried cancellation terms and improper health-data sharing
- Has operated under at least three different legal entity names (FitRX LLC, Zealthy Inc., Gronk Inc.) since 2022
None of this is unique to Zealthy — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. Zealthy is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Zealthy's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Zealthy's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.